Khaitan & Co Advises RPG Life Sciences on Wholly-Owned Subsidiary Formation for API Business

• RPG Life Sciences Limited has carved out its active pharmaceutical ingredients (API) business into a wholly-owned subsidiary company, RPG Active Pharma Limited.
• Khaitan & Co advised RPG Life Sciences on the business carve-out and subsequent investment by PE-investor InvAscent.
• The transaction team at Khaitan & Co consisted of experienced lawyers who worked closely with RPG Life Sciences to ensure a smooth transition.
• The creation of a wholly-owned subsidiary company for the API business is a common practice in the pharmaceutical industry, allowing companies to separate their core operations from other business segments.

RPG Life Sciences Limited has carved out its active pharmaceutical ingredients (API) business into a wholly-owned subsidiary company, RPG Active Pharma Limited.

RPG Life Sciences Limited has taken a significant step in its business strategy by carving out its active pharmaceutical ingredients (API) business into a wholly-owned subsidiary company, RPG Active Pharma Limited. This move is part of the company's efforts to restructure and optimize its operations. The carve-out was advised by Khaitan & Co, a leading law firm in India. The transaction team at Khaitan & Co consisted of experienced lawyers who worked closely with RPG Life Sciences to ensure a smooth transition.

The creation of a wholly-owned subsidiary company for the API business is a common practice in the pharmaceutical industry, allowing companies to separate their core operations from other business segments. This structure can provide tax benefits, improved financial reporting, and enhanced operational flexibility. However, it also raises compliance exposures, particularly with regards to regulatory requirements and intellectual property laws. Lawyers advising clients on business restructuring should take note of this carve-out as a precedent for future transactions.

The RPG Life Sciences' API business carve-out is significant not only for the company but also for the broader pharmaceutical industry in India. The move demonstrates the growing trend of companies restructuring their operations to optimize performance and comply with regulatory requirements. As a wholly-owned subsidiary, RPG Active Pharma Limited will be subject to separate financial reporting, tax obligations, and regulatory compliance. This development may create new opportunities for investment and partnerships in the API business segment.

Lawyers advising clients on business restructuring should note the carve-out of RPG Life Sciences' API business, which may create new compliance exposures and precedent for future transactions.

Source: Original reporting via Bar & Bench